261 related articles for article (PubMed ID: 34058271)
41. Topical application of a G-Quartet aptamer targeting nucleolin attenuates choroidal neovascularization in a model of age-related macular degeneration.
Leaderer D; Cashman SM; Kumar-Singh R
Exp Eye Res; 2015 Nov; 140():171-178. PubMed ID: 26368850
[TBL] [Abstract][Full Text] [Related]
42. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy.
Baek J; Lee JH; Jung BJ; Kook L; Lee WK
Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2309-2317. PubMed ID: 30259090
[TBL] [Abstract][Full Text] [Related]
43. Metabolic physiology in age related macular degeneration.
Stefánsson E; Geirsdóttir A; Sigurdsson H
Prog Retin Eye Res; 2011 Jan; 30(1):72-80. PubMed ID: 20951826
[TBL] [Abstract][Full Text] [Related]
44. Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
Sadda SR; Tuomi LL; Ding B; Fung AE; Hopkins JJ
Ophthalmology; 2018 Jun; 125(6):878-886. PubMed ID: 29477692
[TBL] [Abstract][Full Text] [Related]
45. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes.
Spraul CW; Lang GE; Grossniklaus HE; Lang GK
Surv Ophthalmol; 1999 Oct; 44 Suppl 1():S10-32. PubMed ID: 10548114
[TBL] [Abstract][Full Text] [Related]
46. Myeloid-resident neuropilin-1 promotes choroidal neovascularization while mitigating inflammation.
Andriessen EMMA; Binet F; Fournier F; Hata M; Dejda A; Mawambo G; Crespo-Garcia S; Pilon F; Buscarlet M; Beauchemin K; Bougie V; Cumberlidge G; Wilson AM; Bourgault S; Rezende FA; Beaulieu N; Delisle JS; Sapieha P
EMBO Mol Med; 2021 May; 13(5):e11754. PubMed ID: 33876574
[TBL] [Abstract][Full Text] [Related]
47. Age-Related Macular or Retinal Degeneration?
Gałuszka M; Pojda-Wilczek D; Karska-Basta I
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241152
[TBL] [Abstract][Full Text] [Related]
48. Nonexudative Macular Neovascularization Supporting Outer Retina in Age-Related Macular Degeneration: A Clinicopathologic Correlation.
Chen L; Messinger JD; Sloan KR; Swain TA; Sugiura Y; Yannuzzi LA; Curcio CA; Freund KB
Ophthalmology; 2020 Jul; 127(7):931-947. PubMed ID: 32247535
[TBL] [Abstract][Full Text] [Related]
49. Anti-Vascular Endothelial Growth Factor Intravitreal Therapy and Macular Ganglion Cell Layer Thickness in Patients with Neovascular Age-Related Macular Degeneration.
Abdolrahimzadeh S; Gharbiya M; Formisano M; Bertini F; Cerini A; Pacella E
Curr Eye Res; 2019 Sep; 44(9):1000-1005. PubMed ID: 30999772
[No Abstract] [Full Text] [Related]
50. Microglia Contribution to the Regulation of the Retinal and Choroidal Vasculature in Age-Related Macular Degeneration.
Alves CH; Fernandes R; Santiago AR; Ambrósio AF
Cells; 2020 May; 9(5):. PubMed ID: 32423062
[TBL] [Abstract][Full Text] [Related]
51. Macular atrophy in patients with long-term anti-VEGF treatment for neovascular age-related macular degeneration.
Munk MR; Ceklic L; Ebneter A; Huf W; Wolf S; Zinkernagel MS
Acta Ophthalmol; 2016 Dec; 94(8):e757-e764. PubMed ID: 27417506
[TBL] [Abstract][Full Text] [Related]
52. Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography.
Nagiel A; Freund KB; Spaide RF; Munch IC; Larsen M; Sarraf D
Am J Ophthalmol; 2013 Nov; 156(5):981-988.e2. PubMed ID: 23972309
[TBL] [Abstract][Full Text] [Related]
53. Bevacizumab for neovascular age-related macular degeneration in China.
Li X; Hu Y; Sun X; Zhang J; Zhang M;
Ophthalmology; 2012 Oct; 119(10):2087-93. PubMed ID: 22818896
[TBL] [Abstract][Full Text] [Related]
54. OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study.
Nassisi M; Lei J; Abdelfattah NS; Karamat A; Balasubramanian S; Fan W; Uji A; Marion KM; Baker K; Huang X; Morgenthien E; Sadda SR
Ophthalmology; 2019 Dec; 126(12):1667-1674. PubMed ID: 31281056
[TBL] [Abstract][Full Text] [Related]
55. Progression of lesion size in untreated eyes with exudative age-related macular degeneration: a meta-analysis using Lineweaver-Burk plots.
Liu TY; Shah AR; Del Priore LV
JAMA Ophthalmol; 2013 Mar; 131(3):335-40. PubMed ID: 23494038
[TBL] [Abstract][Full Text] [Related]
56. Dendrimer mediated targeted delivery of sinomenine for the treatment of acute neuroinflammation in traumatic brain injury.
Sharma R; Kambhampati SP; Zhang Z; Sharma A; Chen S; Duh EI; Kannan S; Tso MOM; Kannan RM
J Control Release; 2020 Jul; 323():361-375. PubMed ID: 32339548
[TBL] [Abstract][Full Text] [Related]
57. DETAILED CHARACTERIZATION OF CHOROIDAL MORPHOLOGIC AND VASCULAR FEATURES IN AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
Gupta P; Ting DSW; Thakku SG; Wong TY; Cheng CY; Wong E; Mathur R; Wong D; Yeo I; Gemmy Cheung CM
Retina; 2017 Dec; 37(12):2269-2280. PubMed ID: 28145972
[TBL] [Abstract][Full Text] [Related]
58. Implementation studies of ranibizumab for neovascular age-related macular degeneration.
Bloch SB
Acta Ophthalmol; 2013 Nov; 91 Thesis7():1-22. PubMed ID: 24206851
[TBL] [Abstract][Full Text] [Related]
59. Intravitreal Bevacizumab with or without Triamcinolone for Wet Age-related Macular Degeneration: Twelve-month Results of a Prospective, Randomized Investigation.
Motarjemizadeh Q; Aidenloo NS; Abbaszadeh M; Sadrinia V
Middle East Afr J Ophthalmol; 2018; 25(1):1-7. PubMed ID: 29899643
[TBL] [Abstract][Full Text] [Related]
60. Choriocapillaris dropout in early age-related macular degeneration.
Lutty GA; McLeod DS; Bhutto IA; Edwards MM; Seddon JM
Exp Eye Res; 2020 Mar; 192():107939. PubMed ID: 31987759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
